Sector dividends Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:02 11/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 273.00 USD | -1.92% |
|
-6.94% | +36.86% |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 73.03x | 4.33x | 3.87x | 15.02x | 18.45x | 13.03B | ||
| 1.04% | 1.2% | 31.26x | 4.18x | 5.63x | 16.88x | 23.61x | 46.05B | ||
| -.--% | -.--% | -20.8x | 21.5x | 240.3x | -22.31x | -21.05x | 43.59B | ||
| -.--% | -.--% | 33.14x | 6.05x | 3.23x | 13.92x | 21.04x | 42.35B | ||
| -.--% | -.--% | 44.77x | 7.58x | 5.15x | 28.21x | 32.46x | 38.86B | ||
| 0.42% | 0.46% | 27.43x | 2.22x | 8.26x | 20.95x | 24.87x | 32.24B | ||
| -.--% | -.--% | 33.16x | 23.79x | 5.43x | 24.65x | 25.79x | 16.28B | ||
| 1.13% | 1.28% | 23.64x | 2.62x | 2.07x | 8.96x | 13.89x | 14.32B | ||
| -.--% | -.--% | 28.12x | 1.33x | 1.86x | 11.4x | 12.99x | 12.78B | ||
| 0.44% | 0.44% | 52.17x | 4.55x | 8.66x | 24.57x | 29.3x | 11.3B | ||
| -.--% | -.--% | -42.18x | 21.14x | 7.03x | 171.73x | -1556.48x | 10.6B | ||
| 0.59% | 0.73% | 38.3x | 4.4x | 4.52x | 19.33x | 31.08x | 10.44B | ||
| -.--% | -.--% | -28.28x | 8.32x | 108.93x | -28.66x | -47.4x | 10.17B | ||
| -.--% | -.--% | -24.37x | 8.42x | 10153.63x | -20.06x | -19.75x | 9.45B | ||
| -.--% | -.--% | -30.22x | 8.78x | 80.02x | -20.18x | -19.56x | 9.73B | ||
| -.--% | -.--% | -341.22x | 2.23x | 10.04x | 59.63x | 78.01x | 8.92B | ||
| -.--% | -.--% | 31.21x | - | 16.33x | 29.8x | 29.11x | 9.39B | ||
| -.--% | -.--% | -15.32x | 644.25x | 10.02x | -16.08x | -15.52x | 9.25B | ||
| 0.32% | 0.44% | 21.87x | 2.33x | 4.39x | 11.78x | 15.03x | 8.71B | ||
| Average | 0.21% | 0.24% | -3.38x | 43.22x | 562.07x | 18.40x | -69.69x | 18.81B | |
| Weighted average by Cap. | 0.26% | 0.29% | 10.57x | 25.34x | 307.69x | 15.18x | -32.43x |
Select your edition
All financial news and data tailored to specific country editions
















